- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 21 Reference Ions Near m/z 449.0402
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000054206 Reliable | 449.0477 | 449.0477 ~ 449.0479 MzDiff: 0.9 ppm |
(3s)-3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one (BioDeep_00002188344) Formula: C21H14O10 (426.0587) |
3.1 (100%) | MALDI - CHCA [NOVOCELL:BACKGROUND] blank |
MSI_000011077 Unreliable | 449.0438 | 449.0438 ~ 449.0438 MzDiff: none |
6-Benzyl-1-(benzyloxymethyl)-5-iodouracil (BioDeep_00000177250) Formula: C19H17IN2O3 (448.0284) |
2.29 (100%) | Mus musculus [UBERON:0012378] muscle layer of urinary bladder |
MSI_000011212 Unreliable | 449.0358 | 449.0358 ~ 449.0358 MzDiff: none |
Cefoxitin sodium (BioDeep_00000015080) Formula: C16H16N3NaO7S2 (449.0327) |
1.77 (100%) | Mus musculus [UBERON:0012378] muscle layer of urinary bladder |
MSI_000010701 Unavailable | 449.0482 | 449.0482 ~ 449.0482 MzDiff: 0.0 ppm |
Pimasertib (BioDeep_00000015464) Formula: C15H15FIN3O3 (431.0142) |
-3 (100%) | Bathymodiolus [UBERON:0009120] gill filament |
MSI_000009326 Unreliable | 449.0358 | 449.0358 ~ 449.0358 MzDiff: none |
Cefoxitin sodium (BioDeep_00000015080) Formula: C16H16N3NaO7S2 (449.0327) |
0.09 (100%) | Mus musculus [UBERON:0004645] urinary bladder urothelium |
MSI_000009409 Unavailable | 449.0438 | 449.0438 ~ 449.0438 MzDiff: none |
6-Benzyl-1-(benzyloxymethyl)-5-iodouracil (BioDeep_00000177250) Formula: C19H17IN2O3 (448.0284) |
-0.35 (100%) | Mus musculus [UBERON:0004645] urinary bladder urothelium |
MSI_000012014 Unavailable | 449.0482 | 449.0482 ~ 449.0482 MzDiff: none |
Pimasertib (BioDeep_00000015464) Formula: C15H15FIN3O3 (431.0142) |
-0.78 (100%) | Bathymodiolus [UBERON:2000211] gill lamella |
MSI_000016514 Unreliable | 449.0479 | 449.0479 ~ 449.0479 MzDiff: 0.0 ppm |
(3s)-3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one (BioDeep_00002188344) Formula: C21H14O10 (426.0587) |
0.72 (100%) | Vitis vinifera [PO:0009086] endocarp |
MSI_000026227 Unreliable | 449.048 | 449.048 ~ 449.048 MzDiff: none |
Iodiconazole (BioDeep_00000180046) Formula: C19H19F2IN4O (484.0572) |
1.8 (100%) | Mus musculus [UBERON:0000913] interstitial fluid |
MSI_000054768 Unreliable | 449.048 | 449.048 ~ 449.048 MzDiff: none |
Pimasertib (BioDeep_00000015464) Formula: C15H15FIN3O3 (431.0142) |
1.76 (100%) | MALDI - DHB [NOVOCELL:BACKGROUND] blank |
MSI_000007733 | 449.048 | 449.048 ~ 449.048 MzDiff: none |
Iodiconazole (BioDeep_00000180046) Formula: C19H19F2IN4O (484.0572) |
1.5 (100%) | Rattus norvegicus [UBERON:0004359] corpus epididymis |
MSI_000012954 Unavailable | 449.0474 | 449.0474 ~ 449.0474 MzDiff: none |
Cefamandole Sodium (BioDeep_00000016807) Formula: C18H17N6O5S2. Na (484.06) |
-0.56 (100%) | Plant [PO:0005020] vascular bundle |
MSI_000013838 Unreliable | 449.0474 | 449.0474 ~ 449.0474 MzDiff: none |
Cefamandole Sodium (BioDeep_00000016807) Formula: C18H17N6O5S2. Na (484.06) |
0.04 (100%) | Plant [PO:0005417] phloem |
MSI_000015232 Unavailable | 449.0474 | 449.0474 ~ 449.0474 MzDiff: none |
Cefamandole Sodium (BioDeep_00000016807) Formula: C18H17N6O5S2. Na (484.06) |
-0.63 (100%) | Plant [PO:0006036] root epidermis |
MSI_000018576 Unreliable | 449.0474 | 449.0474 ~ 449.0474 MzDiff: none |
Cefamandole Sodium (BioDeep_00000016807) Formula: C18H17N6O5S2. Na (484.06) |
1.72 (100%) | Plant [PO:0020124] root stele |
MSI_000025889 Unreliable | 449.0429 | 449.0429 ~ 449.0429 MzDiff: none |
6-Benzyl-1-(benzyloxymethyl)-5-iodouracil (BioDeep_00000177250) Formula: C19H17IN2O3 (448.0284) |
2.02 (100%) | Mus musculus [UBERON:0000913] interstitial fluid |
MSI_000033848 Unreliable | 449.0468 | 449.0468 ~ 449.0468 MzDiff: none |
(3s)-3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one (BioDeep_00002188344) Formula: C21H14O10 (426.0587) |
0.41 (100%) | Posidonia oceanica [PO:0005352] xylem |
MSI_000035775 Unavailable | 449.0468 | 449.0468 ~ 449.0468 MzDiff: none |
(3s)-3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one (BioDeep_00002188344) Formula: C21H14O10 (426.0587) |
-0.35 (100%) | Posidonia oceanica [PO:0006203] pericycle |
MSI_000037220 Unreliable | 449.0477 | 449.0477 ~ 449.0477 MzDiff: none |
(3s)-3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one (BioDeep_00002188344) Formula: C21H14O10 (426.0587) |
2 (100%) | Posidonia oceanica [UBERON:0000329] hair root |
MSI_000050408 Unreliable | 449.0476 | 449.0476 ~ 449.0476 MzDiff: none |
Pimasertib (BioDeep_00000015464) Formula: C15H15FIN3O3 (431.0142) |
0 (100%) | Mytilus edulis [UBERON:0009120] gill filament |
MSI_000051322 Unreliable | 449.0476 | 449.0476 ~ 449.0476 MzDiff: none |
Pimasertib (BioDeep_00000015464) Formula: C15H15FIN3O3 (431.0142) |
0 (100%) | Mytilus edulis [UBERON:2001856] gill ray |
Found 11 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
6-Benzyl-1-(benzyloxymethyl)-5-iodouracil Formula: C19H17IN2O3 (448.0284) Adducts: [M+H]+ (Ppm: 18.1) |
Mus musculus (Urinary bladder) |
HR2MSI_mouse_urinary_bladder - S096Resolution: 10μm, 260x134
Mass spectrometry imaging of phospholipids in mouse urinary bladder (imzML dataset) |
|
Cefamandole Sodium Formula: C18H17N6O5S2. Na (484.06) Adducts: [M+H-2H2O]+ (Ppm: 2.9) |
Plant (Root) |
MPIMM_035_QE_P_PO_6pmResolution: 30μm, 165x170
|
|
Iodiconazole Formula: C19H19F2IN4O (484.0572) Adducts: [M+H-2H2O]+ (Ppm: 10) |
Homo sapiens (Liver) |
20171107_FIT4_DHBpos_p70_s50Resolution: 50μm, 70x70
|
|
6-Benzyl-1-(benzyloxymethyl)-5-iodouracil Formula: C19H17IN2O3 (448.0284) Adducts: [M+H]+ (Ppm: 16.1) |
Mus musculus (Lung) |
image1Resolution: 40μm, 187x165
Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin.
Fig 1-3, Fig S1-S3, S5 |
|
6-Benzyl-1-(benzyloxymethyl)-5-iodouracil Formula: C19H17IN2O3 (448.0284) Adducts: [M+H]+ (Ppm: 10.1) |
Mus musculus (Lung) |
image3Resolution: 40μm, 146x190
Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
Iodiconazole Formula: C19H19F2IN4O (484.0572) Adducts: [M+H-2H2O]+ (Ppm: 0.2) |
Mus musculus (Lung) |
image4Resolution: 40μm, 162x156
Fig 6c
Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
6-Benzyl-1-(benzyloxymethyl)-5-iodouracil Formula: C19H17IN2O3 (448.0284) Adducts: [M+H]+ (Ppm: 10.5) |
Mus musculus (Lung) |
image5Resolution: 40μm, 163x183
Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and
U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion
images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079
([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green).
Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. |
|
6-Benzyl-1-(benzyloxymethyl)-5-iodouracil Formula: C19H17IN2O3 (448.0284) Adducts: [M+H]+ (Ppm: 19.2) |
Mus musculus (Lung) |
image2Resolution: 40μm, 550x256
Supplementary Figure S6. Ion distribution images for (a) [PC36:4+Na]+ (m/z 804.5514) and (b)
[PC38:6+Na]+ (m/z 828.5515) obtained from mouse lung tissue collected 6 h after administration of D9-
choline and U13C-DPPC–containing CHF5633. Parts-per-million (ppm) mass errors are indicated in
parentheses. (c) Magnification of the boxed region in (a) with selected bronchiolar regions outlined in
white boxes. (d) The corresponding H&E-stained tissue section with the same selected bronchiolar
regions outlined in black boxes. These data demonstrate the co-localisation of the polyunsaturated lipids
PC36:4 and PC38:6 with the bronchiolar regions of the lung. All MSI images were visualised using
total ion current normalisation and hotspot removal (high quantile = 99%). |
|
(3s)-3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one Formula: C21H14O10 (426.0587) Adducts: [M+Na]+ (Ppm: 2.5) |
Posidonia oceanica (root) |
20190614_MS1_A19r-20Resolution: 17μm, 262x276
Seagrasses are one of the most efficient natural sinks of carbon dioxide (CO2) on Earth. Despite covering less than 0.1% of coastal regions, they have the capacity to bury up to 10% of marine organic matter and can bury the same amount of carbon 35 times faster than tropical rainforests. On land, the soil’s ability to sequestrate carbon is intimately linked to microbial metabolism. Despite the growing attention to the link between plant production, microbial communities, and the carbon cycle in terrestrial ecosystems, these processes remain enigmatic in the sea. Here, we show that seagrasses excrete organic sugars, namely in the form of sucrose, into their rhizospheres. Surprisingly, the microbial communities living underneath meadows do not fully use this sugar stock in their metabolism. Instead, sucrose piles up in the sediments to mM concentrations underneath multiple types of seagrass meadows. Sediment incubation experiments show that microbial communities living underneath a meadow use sucrose at low metabolic rates. Our metagenomic analyses revealed that the distinct community of microorganisms occurring underneath meadows is limited in their ability to degrade simple sugars, which allows these compounds to persist in the environment over relatively long periods of time. Our findings reveal how seagrasses form blue carbon stocks despite the relatively small area they occupy. Unfortunately, anthropogenic disturbances are threatening the long-term persistence of seagrass meadows. Given that these sediments contain a large stock of sugars that heterotopic bacteria can degrade, it is even more important to protect these ecosystems from degradation. |
|
(3s)-3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one Formula: C21H14O10 (426.0587) Adducts: [M+Na]+ (Ppm: 0.5) |
Posidonia oceanica (root) |
20190828_MS1_A19r-22Resolution: 17μm, 292x279
|
|
(3s)-3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one Formula: C21H14O10 (426.0587) Adducts: [M+Na]+ (Ppm: 0.5) |
Posidonia oceanica (root) |
MS1_20180404_PO_1200Resolution: 17μm, 193x208
|
|